Ligand validation:4ZV5

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 4ZV5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4ZV5_MYR_B_101	54%	64%	0.115	0.88	0.47	0.9	-	-	1	0	100%	1
4ZV5_MYR_A_101	51%	53%	0.114	0.868	0.36	1.44	-	3	1	0	100%	1
5HYB_MYR_B_101	54%	67%	0.128	0.893	0.55	0.7	-	-	0	0	100%	1
9JGF_MYR_B_604	100%	60%	0.031	0.991	0.53	0.98	-	1	0	0	100%	1
9LVX_MYR_B_104	100%	70%	0.032	0.99	0.36	0.79	-	-	3	0	100%	1
4G0S_MYR_B_300	100%	64%	0.034	0.987	0.61	0.78	-	-	0	0	100%	1
8RQZ_MYR_A_201	100%	56%	0.048	0.993	0.65	1.05	-	-	2	0	100%	1
3A73_MYR_A_1005	99%	46%	0.049	0.98	0.51	1.55	-	2	6	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.